针对新型MASH治疗,对循环林B向三向量抑制剂的优化
Maria-Eleni Kouridaki1, Jonathan Gillespie2, John Robinson2
1EaStCHEM School of Chemistry, University of Edinburgh, David Brewster Road, Edinburgh, Scotland EH9 3FJ, U.K.
Journal of medicinal chemistry
|March 12, 2025
概括
新药候选药物在治疗代谢功能障碍相关的脂肪肝炎 (MASH) 中表现有前途,通过选择性抑制肝纤维化的关键因素环素B. 这项研究推动了针对MASH的向治疗.
科学领域:
- 生物化学 生化学
- 药理学 药理学是指药理学的学科.
- 肝病学 肝病学是一种肝病学.
背景情况:
- 环素与代谢功能障碍相关的脂肪肝炎 (MASH) 病理生理学有关.
- 抑制环林B可能会减少MASH中的肝纤维化.
- 现有的抑制剂缺乏异型选择性,需要新的方法.
研究的目的:
- 开发用于MASH的异型选择性环菲林抑制剂.
- 为了解决基因毒性和改善环林抑制剂的药物特性.
- 在MASH细胞模型中评估疗效.
主要方法:
- 新型三向量小分子抑制剂的结构-活性关系研究.
- 开发针对环保素多个口袋的化合物.
- 对基因毒性,亚型选择性和药物动力学概况的评估.
- 在MASH细胞模型中进行体外试验.
主要成果:
- 标识化合物11,一个强大的环林B抑制剂.
- 在亚型选择性和药物特性方面有明显的改善.
- 化合物11在MASH细胞模型中表现出强烈的疗效.
- 化合物11的令人鼓舞的药理动力学特征.
结论:
- 新型三向量抑制剂提供了改善的环素B异型选择性.
- 化合物11是MASH治疗的有希望的候选者.
- 对于MASH治疗,需要进一步开发化合物11.
更多相关视频
05:17Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay
Published on: February 9, 2021
1.5K
10:33Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
Published on: October 26, 2015
11.3K
相关概念视频
02:57Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
02:50Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K